Drug Makers Agree to Negotiate With Medicare on Prices of 10 Medicationsnews2023-10-03T22:38:52+00:00October 3rd, 2023|The New York Times|
Supporters of Aid in Dying Sue N.J. Over Residency Requirementnews2023-09-16T09:02:08+00:00September 16th, 2023|The New York Times|
Justice Dept. Asks Supreme Court to Hear Abortion Pill Casenews2023-09-08T23:06:10+00:00September 8th, 2023|The New York Times|
Mallinckrodt’s Bankruptcy Plan Would Cut Payments to Opioid Victims by $1 Billionnews2023-08-23T20:33:07+00:00August 23rd, 2023|The New York Times|
Opioid Settlement Money Is Being Spent on Police Cars and Overtimenews2023-08-15T00:03:26+00:00August 15th, 2023|The New York Times|
Drugmakers Throw ‘Kitchen Sink’ to Halt Medicare Price Negotiationsnews2023-07-23T07:00:18+00:00July 23rd, 2023|The New York Times|
How Gilead Profited by Slow-Walking a Promising H.I.V. Therapynews2023-07-22T18:26:55+00:00July 22nd, 2023|The New York Times|
Merck Sues Over Medicare Drug-Price Negotiation Lawnews2023-06-06T18:41:33+00:00June 6th, 2023|The New York Times|
U.S. Sues to Block Amgen’s $27.8 Billion Takeover of Horizon Therapeuticsnews2023-05-16T18:16:56+00:00May 16th, 2023|The New York Times|
Gilead Wins Key Patent Rights Suit Over HIV Prevention Drug PrEPnews2023-05-09T17:34:57+00:00May 9th, 2023|The New York Times|
